Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 725
Zone

ESSEX BIO-TECHNOLOGY LIMITED

Exhibitor at CPHI Americas 2026
About Us

Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic fibroblast growth factors (FGF), having six flagship biologics approved for a wide range of indications since 1998.

Our portfolio of products aim to deliver solutions to commercial and clinical unmet needs, covering a wide range of therapeutic areas, which include Ophthalmology, Dermatology and Wound Healing.

These products are available in more than 14,000 hospitals, managed directly by our 44 regional sales offices.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2025
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 725

Products Featured at CPHI Americas 2026

  • rb-basic Fibroblast growth factors preparations

    Product rb-basic Fibroblast growth factors preparations

    Ophthalmology:•Corneal defects •Corneal abrasion •Punctate keratopathy and recurrent punctate keratopathy •Mild to moderate dry eye disease •Post operative use •Herpes simplex keratitis •Ballous keratitis Mild to moderate chemical burns
    Surgical (Wound Care and Healing)...

ESSEX BIO-TECHNOLOGY LIMITED Resources (1)